JAGX 8-K 2026-09-24

Jaguar Health, Inc. (JAGX) 8-K dated 2026-09-24 — accession 0001193125-26-401239. This URL is the filing, not the JAGX hub.

Jaguar Health, Inc. (JAGX) is a biotechnology company listed on NASDAQ.

Jaguar Health, Inc. filed a 8-K on 2026-09-24. Accession 0001193125-26-401239.

Cached items: 1.01, 1.02, 3.02, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported JAGX revenue for 2025-12-31 was $11.5M. Net income was -$53.6M. Revenue was down 1.5% from 2024-12-31 to 2025-12-31. JAGX currently screens at market cap $1.7M.

Not investment advice. The JAGX SEC hub lists recent forms. The stock page is the research view.